Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia.
Transverse tubule (TT) membrane vesicles have been isolated from the skeletal muscle of normal and malignant hyperthermia-susceptible (MHS) pigs. MHS and normal TT did not differ in the distribution of the major proteins, cholesterol, or phospholipid content, (Na+ + K+)-ATPase activity, [3H]ouabain binding, Ca2+-ATPase activity, Mg2+-ATPase activity, or [3H]saxitoxin binding. Furthermore, in the presence of micromolar Ca2+, MHS and normal TT did not differ significantly in the KD values for either [3H]nitrendipine binding (2.7 +/- 0.6 and 3.3 +/- 0.5 nM, respectively) or (-)-[3H]desmethoxyverapamil ([3H]D888) binding (7.2 +/- 0.9 and 6.4 +/- 0.6 nM, respectively). However, in contrast to normal TT, MHS TT exhibited a significantly decreased Bmax for both [3H]nitrendipine binding (26.4 +/- 5.4 for MHS versus 40.6 +/- 3.7 pmol/mg protein for normal TT) and [3H]D888 binding (17.8 +/- 7.0 for MHS versus 37.4 +/- 5.9 pmol/mg protein for normal TT). At calcium concentrations greater than 0.1 mM, there was a greater inhibition of [3H]nitrendipine binding to normal than to MHS TT such that binding was now similar for both preparations. As with purified TT, [3H]nitrendipine binding to MHS muscle homogenates was significantly less than to normal muscle homogenates (109 +/- 20 versus 211 +/- 19 fmol/mg protein, for MHS and normal TT, respectively); this difference was not apparent when 100 mM CaCl2 was included in the binding medium. We conclude that the altered MHS TT dihydropyridine receptor properties may reflect an adaptation of the TT voltage sensing mechanism to the abnormal sarcoplasmic reticulum calcium release channel regulation in MHS muscle.
Ervasti
J M
JM
Department of Biochemistry, University of Minnesota, St. Paul 55108.
Claessens
M T
MT
Mickelson
J R
JR
Louis
C F
CF
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D015220:Calcium Channels; D007700:Kinetics; D008305:Malignant Hyperthermia / Q000378:metabolism / Q000662:veterinary*; D009132:Muscles / Q000378:metabolism*; D009568:Nitrendipine / Q000378:metabolism*; D015388:Organelles / Q000378:metabolism*; D010042:Ouabain / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000378:metabolism*; D012016:Reference Values; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013552:Swine; D013553:Swine Diseases / Q000378:metabolism*; D014700:Verapamil / Q000031:analogs & derivatives* / Q000378:metabolism
D015220:Calcium Channels; D011978:Receptors, Nicotinic; D010042:Ouabain; C043184:4-desmethoxyverapamil; D009568:Nitrendipine; D014700:Verapamil; D000251:Adenosine Triphosphatases; D000254:Sodium-Potassium-Exchanging ATPase